Researchers in Japan have established that, in patients with metastatic esophageal cancer, lymph node response to neoadjuvant chemotherapy more accurately predicts long-term survival than primary tumor response
Lymph Node Response Can Prognosticate Long-Term Survival in Patients With Esophageal Cancer